Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Hallinan Z"'
Autor:
Kehoe L; Clinical Trials Transformation Initiative, Duke Clinical Research Institute, 300 West Morgan Street, Suite 800, Durham, NC, 27701, United States., Calvert SB; Clinical Trials Transformation Initiative, Duke Clinical Research Institute, 300 West Morgan Street, Suite 800, Durham, NC, 27701, United States., Hallinan Z; Clinical Trials Transformation Initiative, Duke Clinical Research Institute, 300 West Morgan Street, Suite 800, Durham, NC, 27701, United States., Hanger M; Clinical Trials Transformation Initiative, Duke Clinical Research Institute, 300 West Morgan Street, Suite 800, Durham, NC, 27701, United States. Morgan.hanger@duke.edu.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Mar 28. Date of Electronic Publication: 2024 Mar 28.
Autor:
Perry B; Clinical Trials Transformation Initiative, Duke University, Durham, NC, USA. brian.perry@duke.edu.; Department of Population Health Sciences, Duke University, 215 Morris Street, Suite 210, Durham, NC, 27701, USA. brian.perry@duke.edu., Dombeck C; Clinical Trials Transformation Initiative, Duke University, Durham, NC, USA.; Department of Population Health Sciences, Duke University, 215 Morris Street, Suite 210, Durham, NC, 27701, USA., Smalley JB; Patient Advocate, New York, NY, USA., Levitan B; Janssen R&D LLC, Titusville, NJ, USA., Leventhal D; Pfizer, Inc, Groton, CT, USA., Patrick-Lake B; Duke Clinical Research Institute, Durham, NC, USA., Brennan L; Cystic Fibrosis Foundation, Washington, DC, USA., McKenna K; Clinical Trials Transformation Initiative, Duke University, Durham, NC, USA.; Department of Population Health Sciences, Duke University, 215 Morris Street, Suite 210, Durham, NC, 27701, USA., Hallinan Z; Clinical Trials Transformation Initiative, Duke University, Durham, NC, USA., Corneli A; Clinical Trials Transformation Initiative, Duke University, Durham, NC, USA.; Department of Population Health Sciences, Duke University, 215 Morris Street, Suite 210, Durham, NC, 27701, USA.; Duke Clinical Research Institute, Durham, NC, USA.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2021 Mar; Vol. 55 (2), pp. 324-335. Date of Electronic Publication: 2020 Sep 29.
Autor:
Geoghegan C; Patient and Partners LLC, Madison, CT, USA., Nido V; Genentech, Inc., South San Francisco, CA, USA., Bemden AB; Arthritis Foundation, Atlanta, GA, USA., Hallinan Z; Clinical Trials Transformation Initiative, Durham, NC, USA., Jordan L; Target Health Inc., New York, NY, USA., Kehoe LS; Clinical Trials Transformation Initiative, Durham, NC, USA., Morin SL; Office of Health and Constituent Affairs, US Food and Drug Administration, Silver Spring, MD, USA., Niskar A; Patient Voice Representative, Atlanta, GA, USA., Okubagzi PG; MedStar Health, Columbia, MD, USA., Wood WA; University of North Carolina, Chapel Hill, NC, USA.
Publikováno v:
Contemporary clinical trials communications [Contemp Clin Trials Commun] 2020 Aug 13; Vol. 19, pp. 100636. Date of Electronic Publication: 2020 Aug 13 (Print Publication: 2020).
Autor:
Corneli A; 1 Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Durham, NC, USA.; 2 Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA., Hallinan Z; 1 Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Durham, NC, USA., Hamre G; 1 Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Durham, NC, USA., Perry B; 1 Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Durham, NC, USA.; 2 Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA., Goldsack JC; 1 Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Durham, NC, USA., Calvert SB; 1 Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Durham, NC, USA., Forrest A; 1 Clinical Trials Transformation Initiative, Duke Clinical Research Institute, Durham, NC, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2018 Feb; Vol. 15 (1_suppl), pp. 13-18.
Publikováno v:
Translational & Clinical Pharmacology. Mar2024, Vol. 32 Issue 1, p30-40. 11p.
Autor:
Getz K; Tufts University, 75 Kneeland Street, Suite 1100, Boston, MA 02111, USA. kenneth.getz@tufts.edu, Hallinan Z, Simmons D, Brickman MJ, Jumadilova Z, Pauer L, Wilenzick M, Morrison B
Publikováno v:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2012 Mar; Vol. 5 (2), pp. 149-56.
Autor:
Ghadessi, Mercedeh1 (AUTHOR), Di, Junrui2 (AUTHOR) junrui.Di@pfizer.com, Wang, Chenkun3 (AUTHOR), Toyoizumi, Kiichiro4 (AUTHOR), Shao, Nan5 (AUTHOR), Mei, Chaoqun6 (AUTHOR), Demanuele, Charmaine2 (AUTHOR), Tang, Rui7 (AUTHOR), McMillan, Gianna8 (AUTHOR), Beckman, Robert A.9 (AUTHOR)
Publikováno v:
Orphanet Journal of Rare Diseases. 4/11/2023, Vol. 18 Issue 1, p1-11. 11p.
Autor:
Evans, Scott R.1 (AUTHOR)
Publikováno v:
Statistics in Biopharmaceutical Research. Apr-Jun2022, Vol. 14 Issue 2, p140-152. 13p.
Publikováno v:
Journal of Clinical Nursing (John Wiley & Sons, Inc.); Mar2024, Vol. 33 Issue 3, p1084-1093, 10p
Autor:
South, Annabelle1 (AUTHOR) a.south@ucl.ac.uk, Joharatnam-Hogan, Nalinie1 (AUTHOR), Purvis, Cara1 (AUTHOR), James, Elizabeth C.1 (AUTHOR), Diaz-Montana, Carlos1 (AUTHOR), Cragg, William J.2 (AUTHOR), Tweed, Conor1 (AUTHOR), Macnair, Archie1 (AUTHOR), Sydes, Matthew R.1 (AUTHOR), Snowdon, Claire3 (AUTHOR), Gillies, Katie4 (AUTHOR), Isaacs, Talia5 (AUTHOR), Bierer, Barbara E.6 (AUTHOR), Copas, Andrew J.1 (AUTHOR)
Publikováno v:
PLoS Medicine. 10/4/2021, Vol. 18 Issue 10, p1-26. 26p. 2 Diagrams, 7 Charts.